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ABSTRACT 
Comparative Studies Of Diverged Members of the 
Phosphotriesterase Family. (April 2002) 
Cristina Gale Arriens 
Department of Biochemistry and Biophysics 
Texas ARM University 
Fellows Advisor: Dr. Melinda E. Wales 
Department of Biochemistry and Biophysics 
Some genes direct the synthesis of specific proteins called enzymes that catalyze specific 
types of chemical reactions. The class of enzyme of interest in this research, the 
hydrolases, catalyzes the conversion of functional groups to water. The 
phosphotriesterase (PTE) family is a subgroup ofhydrolases that breaks down 
organophosphate compounds (OPs). Many organophosphate compounds are potent 
cholinesterase inhibitors, accounting for their widespread use as insecticides and nerve 
agents. Enzymes have been found in bacteria and higher organisms that specifically 
breakdown OPs. One of these enzymes, human serum paraoxonase/arylesterase (PON I), 
is a calcium-dependent, HDL (High Density Lipoprotein) -associated protein that 
appears to have multiple roles in viva. In one guise, PON I hydrolyses organophosphate 
insecticides and nerve gases and is responsible for determining the selective toxicity of 
these compounds in mammals. I)sing the sequence available in NCBI Genebank, 
primers flanking the coding region of PONI were designed and used to screen a human 
liver cDNA library using polymerase chain reaction (PCR). A single band corresponding 
to the approximate size of PONI, 1kb, was amplified and subsequently cloned. The 
identity of the cloned region as PONI was verified by sequencing using PON I specific 
primers, and then cloned into a plasmid named pTYBI Irom the IMPACT-CN 
expression system. Expression was obtained using the BL21-star bacterial strain. The 
enzyme was found within an inclusion body, and solubilized with urea and DTT. 
Preliminary activity studies were unsuccessful, so further manipulation of the insoluble 
traction is necessary to obtain proper folding. 
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INTRODUCTION 
Some genes direct the synthesis of specific proteins called enzymes. Enzymes catalyze 
chemical reactions, and one of their most impressive characteristics is the specificity of 
their action. The specificity enzymes exhibit is two-fold, they are typically specific to the 
type of chemical reaction as well as to the physical nature of the substrate subjected to 
that reaction. With this in mind, the International Commission on Enzymes in 1956 
devised six broad classes of enzymes based on the reaction catalyzed: oxidoreductases, 
transferases, hydrolases, lyases, isomerases, and ligases (5). 
The class of enzyme of interest in this research, the hydrolases, catalyzes the conversion 
of functional groups to water. The phosphotriesterase (PTE) family is a subgroup of 
hydrolases that breaks down organophosphate compounds (OPs). Many 
organophosphate compounds are potent cholinesterase inhibitors, accounting for their 
widespread use as insecticides and nerve agents. In addition to the nearly 3 million cases 
of pesticide poisonings world-wide each year attributed to OP pesticides, there are risks 
associated with the international effort to destroy the approximately 25, 000 tons of 
chemical agents (5). Additionally, the widespread repeated exposure to chemical agents 
(including organophosphate pesticides and nerve gases, DEET, and pyridostigmine) 
which occurred during the Gulf War could be associated with the neurological 
symptoms of some Gulf War Veterans (6). 
This thesis follows the style and format of the Journal of Bacteriology. 
The most extensively characterized member of the PTE family is organophosphorus 
hydro lase (OPH), a bacterial enzyme that hydrolyzes a broad variety of organophosphate 
neurotoxins. The substrate range of OPH includes several insecticides, the neurotoxic 
chemical warfare agents and their analogs. All of the phosphate triesters found to be 
substrates of OPH are synthetic compounds, and the identity of any naturally occurring 
substrate for the enzyme is unknown. 
Since the initial characterization of OPH, other enzymes have been identified which 
accomplish this hydrolysis for specific classes of OP compounds. One of these 
enzymes, human serum paraoxonase/arylesterase (PON I) is a calcium-dependent, HDL 
(High Density Lipoprotein) -associated protein that appears to have multiple roles in 
vivo (5). In one guise, PONI hydrolyses organophosphate insecticides and nerve gases 
and is responsible for determining the selective toxicity of these compounds in 
mammals. At this time, human PON I is known to utilize a broad group of substrates 
including: OP insecticides such as paraoxon, chlorpyrifos oxon, and diazoxon; nerve 
agents such as soman and sarin (4); and lactones (I). 
Although PON1 shows no homology to any of the proteins with which it shares 
functional similarity (the bacterial PTEs, including OPH), it is a member of a multigene 
family composed of three distinct, closely linked genes (PON1, PON2 and PON3). 
PON1 is believed to be expressed in the liver, brain, and lung and its encoding gene is 
located at q21-q22 on the long arm of chromosome 7 (7). Sequencing of the human 
PON I gene identified two genetic polymorphisms distinguished by amino acid 
substitutions at positions 55 and 192 (5). The arginine 192 isoform (PONI xiii) 
hydrolyzes Paraoxon about six times as fast as the glutamine 192 isoform (PON1Qna) 
(4). However, PON1Q/9$ hydrolyzes diazoxon, soman, and sarin at a faster rate than 
PONls~gz (3). The other polymorphism gives either a leucine or a methionine at amino 
acid 55, with leucine having a higher paraoxon hydrolysis activity (7). The widely 
debated Gulf War Syndrome could be connected with a decreased capacity to detoxify 
OP insecticides resulting &om low serum PON1 activity in both the PONlmqq and 
PONlotgt iso forms (8). 
Like the PON1 gene, PON2 and PON3 are located on chromosome 7, and although the 
protein products ofhuman PON2 and PON3 have not been isolated, tissue distribution of 
PON2 transcripts were observed to be highest in liver, brain, and heart tissue (5). The 
similarity within the PON genes strongly suggests that these related genes arose by gene 
duplication. Similar to PON1, PON2 contains a common polymorphism at codon 311 
and some population studies indicate that the PON2 S allele may contribute to an 
increased risk for coronary heart disease (5). 
MATERIALS AND METHODS 
CHEMICAL AND BIOLOGICAL REAGENTS 
The 7 TriplEx human liver cDNA library was purchased I'rom Clontech (Palo Alto, CA), 
and the manufacturer's protocol for titering and amplification was followed. PCR 
reactions were carried out with Ready-To-Go PCR Beads (Amersham Pharmacia 
Biotech, Inc. , Piscataway, NJ) in a Perkin Elmer DNA Thermal Cycler (Perkin Elmer 
Corporation, Norwalk, CT), using standard PCR conditions. Cloning and expression 
vectors (Table I) were purchased from Clontech and New England Biolabs. 
TABLE 1. Plasmids used in this study 
Plasmid Description 
p T-Adv (Clontech) AT Linear cloning vector, Ap' 
pCRT7-TOPO (Clontech) AT Linear cloning vector, Ap', Zeo' 
pTYB I (New England Biolabs) Expression vector, Ap", lacZ' 
Plasmid templates were purified for use in PCR and sequencing reactions using Qiagen 
Plasmid Mini and Midi Kits (Qiagen, Inc. , Valencia, CA). Primers (Table 2) were 
synthesized by the Gene Technologies Laboratory, using an Applied Biosystems 394T 
DNA/RNA Synthesizer. DNA sequences were determined using the BigDye DNA 
Sequencing Kit (Applied Biosystems, Foster City, CA) following the instructions of the 
manufacturer. 
TABLE 2. Primers, sequence indicated is written 5' — 3' 
Purpose Primer Sequence 
Library 
screening 
3PON5' 
PON3' 
2PON3int 
PON3int 
3PON3 
2PON5jnt 
PON581t 
3PON5int 
CCGACCATGGCGAAGCTG 
ATGGCATGGGTGCAAATCGGTCTGTT 
TTGGGTTTAGCGTGGTCGTATGTTGTC 
ATGCCATGTACCTCCTGGTGGTGAACC 
GCATGGGTGCAAATCGGTCTG 
CTTGCCATCGGGTGAAATGTTGATTCC 
TGCCAT~GTGCTCAGGTCCCACAG 
CATAAAAGTGCTCAGGTCCCA 
Sequencing M13 Forward 
M13 Reverse 
PON I-201a 
PON1-201 
Intein Reverse 
T7 Forward 
T7 Reverse 
V5 Forward 
CCCAGTCACGACGTTGTAAAACG 
AGCGGATAACAATTTCACACAGG 
TTCATTTAACCCTCATGGGA 
GAGCCAGCAACTCAGCTATA 
ACCCATGACCTTATTACCAACCTC 
TAATACGACTCACTATAGGG 
TATGCTAGTTATTGCTCAG 
ACCGAGGAGAGGGTTAGGGAT 
Restriction site 
insertion 
ponl-ndel 
ponl-sap 
pon I -Gsap 
pon1-sap* 
pon1-sap+ 
CGGCTTCCGCATATGGCGAAGCTGATTGCG 
GCTCTTCCGCATTAGAGCTCACAGTAAAGAGC 
GGTGGTTGCTCTTCCGCATTAGAGCTCACAGT 
AAAGAGC 
GCTCTTCTCTGTTAGAGACAGTAAAGAGC 
CGGCTTATGGCATGGGTGCGCTCTTCTCTGTTA 
GAGACAGTAAAGAGC 
Reactions were run on Applied Biosystems ABI 373XL and 377XL Automated 
Sequencers at the Gene Technologies Laboratory at Texas A&M University. Restriction 
enzymes were purchased Irom Promega Corporation (Madison, WI) or New England 
Biolabs, Inc. (Beverly, MA). SDS-PAGE molecular weight standards and all other 
chemicals, including IPTG, were obtained from Sigma Chemical Co. (St. Louis, MO). 
Bacterial strains (Table 3) were purchased from Invitrogen (Carlsbad, CA) and New 
England Biolabs, Inc. (Beverly, MA). All strains were grown in Luria-Bertani medium 
(I'/e Bacto tryptone (Difco, Detroit, MI), 0. 5'/e Bacto yeast extract, 0. 5'/e NaCl, 
supplemented with 1. 5'/e Bacto agar, when necessary) with vigorous shaking at 37 'C. 
Bug Buster Protein Extraction Reagent (Novagen, Inc. , Madison, WI) was used to lyse 
cells aller expression. 
TABLE 3. Bacterial strains used in this study 
Strain 
XL I -Blue E. coli 
ER2566 E. coli 
Rosetta I 
Top 10F' E. coli 
DH5a E. coli 
BL21-star 
Genotype 
endAI, gyrA96, hsdR17, lac, recAI, relAI, supE44, thi-l, 
(FqaclqZDMI5, proAB, Tn 10J 
F 2. JhuA2(lonj ompTlacZ::T7genel gal 
sulAI ID(mcrC-mrr)114:: IS)OR (mcr-73:: mini Tn10-TetS)2 
R(zgh-210:: Tn1 0) (TetS) endA 1(dern J 
F — ompT hsdS (r m ) gal dcm lacYI pRARE2 (Cm ) 
F'(lacls Tn10(Tet )) mcrA A (mrr-hsdRMS-mcrBC) 
rP80lacZDM15 A lacx74 deoR recA I araD139 A (ara-leu) 
7697 galU galK rpsL endAI nupG 
F' rft80d lac A M15 A PacZYA-argF) U169 endAI rel A I 
hsdRI 7(r x-m x+) deoR thi-I phoA supE44 2 gyrA96 
F ompThsdSe (rs-me-) gal dcm rne131 (DE3) 
pRARE: This is a ColEl, chloramphenicol-resistant plasmid which supplies tRNAs under the control of 
their native promoters for the codons AUA, AGG, AGA, CUA, CCC and GGA, facilitating expression of 
genes that encode rare E. coli codons. 
LIBRARY TITER 
Overnight culture of XL1-Blue E. co/i was centrifuged at 5, 000 RPM for 5 minutes to 
pellet the cells. A&er decanting the supernatant, the pellet was resuspended in 10mM 
MgSO4. A I:10, 000 dilution of the library was prepared and mixed with 200 ItL of cells 
in the following amounts; 0 ItL, 5 ItL, 10 pL, and 20 ItL. Each was added to a 4 mL tube 
of melted top agar and poured over LB agar plates. After hardening, they were 
incubated at 37'C for 7 hours. Then, the plaques were counted to calculate the titer in 
pfu/mL by the following equation: 
(number of plaques 10 10' itL/mL)/ ItL of diluted phage 
LIBRARY SCREENING 
The ponl sequence was retrieved &om the NCBI GenBank database, entry NM 000446. 
Polymerase Chain Reaction (PCR) primers were designed to match the sequence at its 
beginning and end and named 3PON5' and PON3'. The library was diluted I:100 and 
mixed with 500 iti of an overnight culture of XLI-Blue E. co/i in 15ml LB with 10 mM 
MgSO~. After a 20 minute room temperature incubation, the mixture was aliquoted into 
a sterile 96-well plastic plate making an 8 x 8 grid. The plate was incubated at 37'C for 
6 hours after which 25 Itl &om each well in row A was pooled. This was repeated for 
each horizontal and vertical series, resulting in 16 pools. Atter boiling 10 minutes, 13 ttl 
of each pool was added to a 0. 5mL PCR bead tube. Then 2 itL of a I:800 dilution of 
each primer and 8 ItL of water were added for a total volume of 25 ttL. The samples 
were then placed in a thermal cycler for an initial 5 minute 95'C denaturation followed 
by 40-cycles of a I minute 95'C denaturation, I minute at 55'C, and a 2 minute 72'C 
elongation step. Each reaction was run on an agarose gel using electrophoresis. Pool ¹2 
had a band 1 kB in length, the size predicted for ponL 
CLONING AND SEQUENCING PON I 
To generate the PCR fragment for cloning, PCR was repeated with Pool ¹2 and a small 
portion was run on a gel to verify the presence of the I kb band. The remaining PCR 
product was mixed with the pT-Adv vector, T4 DNA ligase, and ligation buffer and 
allowed to ligate overnight at 14'C. The resulting circular plasmid was then mixed with 
Top 1 OF' chemically competent cells and 0. 5M P-mercaptoethanol. The mixture sat on 
ice 30 minutes, was heat shocked at 42'C for 30 seconds, returned to ice 2 minutes, then 
250 ltl LB was added. After I hour at 37 C, the mixture was spread on IPTG/X-gal LB 
agar plates and incubated at 37'C overnight. Twenty white colonies were picked and 
used to inoculate a 5 mL tube of LB and an LB agar plate, both containing 100 Itg(ml 
ampicillin. Rapid plasmid preparations utilizing a pheno Vchloro form extraction and an 
ethanol precipitation were used to isolate the plasmid DNA. This was then used in PCR 
along with the M13 forward and reverse primers which flank the AT cloning region. 
The PCR products were run on a gel and two of them appeared to have products about I 
kb in size. The primer set originally used to locate the gene was used in PCR with the 
two samples and confirmed the previous result. Overnight cultures from the two 
positive colonies (¹20 and ¹22) on the LB agar plate were started in 100mL of LB with 
ampicillin. Plasmid was purified using the Qiagen Midi kit according to manufacturers 
instructions, yielding 140 Itg/ml of pT-Adv-Ponl-20 and 190 Itg/ml of pT-Adv-Pon1-22. 
To verify the fiagment as PON I, the fiagment was sequenced. Three pmol of M13 
forward and reverse primers were used separately with 150 ng of p T-Adv-Ponl-20 or 
p T-Adv-Pon1-22, and 2 pl of Big Dye. The samples were cleaned using Bio-Rad Micro 
Bio-Spin P-30 purification columns, according to the manufacturers protocol. The 
samples were dried and submitted to the Gene Technologies Lab of the Institute of 
Developmental /k Molecular for analysis. The sequencing protocol was repeated using 
internal primers PON I-201a and PONI-201 to obtain the complete sequence of the gene. 
INTRODUCTION OF RESTRICTION SITES 
Primers PONI-sap and PONI-nde were used in PCR with the p T-Adv-Pon 20 plasmid to 
introduce a Sapl site on the 3' end and a Ndel site on the 5' end. The PCR products were 
ligated with the pCRT7-TOPO and incubated at room temperature for 10 minutes. The 
ligation was immediately transformed into Top 1 OF' competent cells and spread on 
LB/zeocin agar plates. PON I-sap and PONI-nde were used to screen the colonies, with 
11 of 12 colonies giving a I kb band on the gel. Two colonies were chosen, 8b and 20b, 
Irom which to isolate DNA and sequence using the T7reverse and V5forward primers. 
CLONING INTO THE EXPRESSION VECTOR 
Single digests were first performed with Ndel and Sapl on 8b, 20b, and p TYBI to insure 
proper cutting. Difficulty achieving complete digestion with Sapi was overcome by 
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incubation at 37'C with 3 units of Sapi added I unit at a time over a 3 hour interval. 
Comparison to uncut samples on an agarose gel showed that the digests were successful. 
Sapi digests were performed as before, except when the 3' unit of Sapl was added I unit 
of Ndel was also added to the three samples. The enzymes were heat inactivated at 70'C 
for 20 minutes. CIP (Calf Intestinal Phosphatase) was added to 8b and 20b to 
dephosphorylate the ends, to prevent self ligation, followed by heat inactivation. The 
pTYBI digest was divided in half and added to the 8b and 20b digests, co-precipitated 
by the addition of ethanol, and resuspended in 15 ItL of water. Four microliters of 5X 
Ligase buffer and I ItL of DNA ligase was added, and the ligation was incubated at 
14'C overnight. The ligation mixtures were transformed into DHSct chemically 
competent cells and spread on LB/ampicillin plates and incubated overnight at 37'C. 
Colonies Irom the transformation plate were picked on an LB/zeocin plate and an 
LB/ampicillin plate and incubated overnight at 37'C. 9 of 10 grew only on ampicillin, 
indicating they contained the pTYBI vector. Colonies 1-6 and 8-10 were screened by 
PCR using the Intein reverse and T7forward primers. 4 colonies were chosen for 
plasmid isolation and sequencing using the T7, Intein, PON20-201, and PON20-201a 
primers. Sequence analysis indicated that PON20-8 was the correct sequence. 
PON I EXPRESSION 
Pon 20-8 DNA was transformed into E. col/ ER2566, Rosetta, and BL21-star hosts. 
Colonies were picked to inoculate two SmL tubes of LB/ampicillin broth and grown at 
37'C for 4 hours, or to an ODqcp of 0. 5-0. 7. At that time, IPTG was added to half the 
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tubes to induce expression of PON1 and growth continued either for 2. 5 hours at 37'C or 
16 hrs. at 15'C. The cells were pelleted and resuspended in 250 Itl of Bug Buster. The 
sample was centrifuged, separating the soluble fraction fiom the insoluble. The pelleted 
insoluble proteins were resuspended in 100 ItL of Bug Buster. Both Iractions were run 
on an SDS- polyacrylamide gel electrophoresis and stained with comassie blue. 
PURIFICATION AND SOLUBILIZATION OF INCLUSION BODIES 
The inclusion body fraction was re-solubilized by resuspension in 5 mL 8M urea, 100 
mM DTT, I mM EDTA, 0. 1 M Tris-HC, pH 8 and incubation for 2 hours at 25'C. The 
pH was lowered to 3 by the dropwise addition of I M HCI. To determine the effect of 
removing DTT from the solubilization buffer, the sample was clarified by centrifugation 
at 10, 000 x g. The supernatant was pipetted into dialysis tubing and dialyzed against 
500 mL 6M urea, 10 mM HCI for 2 hours at 25 C and again against I liter 6 M urea at 
4'C overnight. The sample appeared cloudy the next day indicating the formation of a 
precipate during dialysis. Centrifugation to separate the soluble and insoluble fractions 
was followed by SDS-PAGE electrophoresis to determine which fiaction contained the 
PONI protein. 
To evaluate the effect of Urea, the re-solubilized inclusion body fraction was diluted to 
achieve a urea step gradient of 8 M, 6 M, 4 M, and 2 M, keeping DTT, EDTA, and Tris- 
HCI levels constant. AAer a 2 hour incubation at room temperature the samples were 
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centrifuged and the pellets resuspended in 8 M urea buffer. The soluble samples were 
run on a gel. 
PAROXONASE SPOT ASSAY 
Four and one-half milliliters of a 20 mM CHES, pH 9 solution was mixed with 0. 5 mL 
of 10 mM paraoxon. Of this solution, 100 ltL was added to a 4 x 3 grid in a 96-well 
plate. The first row was a buffer control that had the 8 M urea solution, 6 M, 4 M, and 2 
M. The next row was a enzyme dilution control that mixed the enzyme in 8M urea 
solution with enzyme-free 8M urea solution in the following ratios: 50pk0ttl, 
37. 5tth12. 5ttl, 25tth251tl, and 12. 5ttl:37. 5 irk The next row mixed the enzyme 
solubilized in 8M urea solution with enzyme-free OM urea solution in the same ratios, 
giving final urea concentrations of 8M, 6M, 4M, and 2M. A known active OPH enzyme 
was added to a final well as a positive control. 
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RESULTS AND DISCUSSION 
LIBRARY TITERING AND SCREENING 
The library titering yielded approximately 10 pfu/mL. According to the manufacturer's 
protocol a successfully amplified library will have a very high titer of approximately 
10 pfu/mL Various primer combinations were initially used in PCR with the library 
pools, but only primer set 8, 3PONS' and PON3', resulted in an amplified product of the 
target size with Pool ¹2 (Fig. I A. ). PCR with Pool ¹2 was repeated with primer set 8 
and also with set 2, PON3int and PON3', to verify the initial result (Fig. I B. ). 
A. 
2 8 con 1kb 
FIG. l. A. Gel of library screening PCR products of Pools 1-8 with negative 
(8/c) and positive (con) consols, and Ikb DNA ladder. In lane 2 there is a I kb band 
Irom Pool ¹2. B. Gel verifying ponl identity using primer set 2 in addition to primer set 
8. Set 2 (lane I) is expected to give a 719 bp product and set 8 (lane 2) is expected to 
give a 1000 bp product. 
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CLOMNG AND SEQUENCING ponl 
Colonies resuking Irom the transformation of DH5. with p TAs~ponl were screened 
using the M13 forward and reverse primers, which flank the gene. Colony ¹20 and ¹22 
each gave a product approximately I kb in size (Fig. 2). 
FIG. 2. Gel showing the PCR products Irom screening of transformants. Colony 
¹20 and ¹22 (bottom row lanes g and 10) gave 1kb products. 
To confirm the screening result, p T-Adv-ponl-20 and p T-Adv-ponl-22 were sequenced. 
The complete sequence was aligned with the known ponl sequence and found to have 
five base pair differences with the published ponl sequence (Fig. 3). Since these 
discrepancies were found in both p T-Adv-ponl-20 and p T-Adv-pon1-22, and repeated 
sequencing of that region gave the same result, these changes are considered allelic 
difference rather than errors introduced during PCR. 
15 
pool-20 
NM 000446 GAATZGZAATA~ATMQQCQAATmQQCCCTCTAOATGCATQCTCG~CCAGTGTOATGQATATCT 
potll — 20 
NH 000446 
ponl-20 
MH 000446 
QCAGAATTCGGCTTCCQaceamGCGAMCZGA~CCCT~AmGGACZQGCACTCTTCIV3QAACCAC 
ATQGCGAAGCZGA TZGCGCI'CACCCTCTIOGGGATGGGacmQCACTCTT~C 
CAQTCIHTACCAAACACGACITAATGCTCTCCQAGAGGTACAACCCOTAGAAC1TCCTAACTGTAATTTAOTTAAAGG 
~accaaacacoacrraamcrercccacacoracaacccQTMAacrrccTAACIQTAATZTMTTAAMQ 
poll I - 2 0 
NM 000446 
aa~~ tlinnUUMTACTGCCTAATGGACmGCTTTCATTAOCTCTGGATTAAAGTATCCTQGAA 
AATCGAAA~AQACA TOGAOATACTGC CZAATGGA~TTAOCT CTGGATTAAAGTATCCTOGAA 
no01. 20 
MH 000446 
TAAAGMcrrcaacccraacaorccmoaaaaaraerrcmarcoaccloaam~rccaa~aarm 
TAAMMtmcaaccccaaCAOTCCIOGAIUIAATACTTCTGATGGACcmaa~aTCCAA~TTG 
Pool. 20 
NH 000446 
GOO ATCACTOQAMTAAATTTOAT3TATCTTZ'ATTTAACC CTCA TOGO ATTAGCACATT CACAO ATGAAGATAATGC CAT 
QooamacramumaaarrmamrarclrcarrraaeecrcamooarzaocacapzcacMamaMATAATGCCAT 
Ponl-20 
MM 000446 
orneere~ccarccaoamccaaQTCCACMmQMrzozrraaa~aMaaaaarcocrrr 
GT~TQOTGAACCATCCAGATGCCAAQTCCACAG~AAATTTCIUU3AAOAAGAAAAATCOCZTT 
ponl-20 
HH 000446 
pot 1-20 
NM 000446 
TQCATcraaaaatmrrllQACATaaa~aarrrcaamaTATTGTTGCTGTOGGACCTGAGCACTTITATGGC 
meamraaaaaccaTCMACATAaacrztmccraarrroaamaralmrmcmmccaccmacKaerrrramcc 
AeaaamaTCACTA~CCCCTAcrltutlt TccmOGMATGTA~AGCGTGGTCGTA~A 
acaaamarcacrarrrrcrlm ccceraerracaa~amrarrmoorzraccomcrcoramrmmra 
p*nl-20 
MH 000446 
pntll-20 
MH 000446 
pont-2O 
NM 000 ~ 46 
Ponl-20 
NN 000446 
1-20 
000446 
pool-20 
NN 000446 
CI'ATAGI'CCAAQTQAAGTtCGAOZOGtoo IIQAIIQOArlmarrITGCTAATGOAATCAACATITCACcccamocaaGT 
CZAT~~~OAMOATTTGATTITQCTAATQGAATCAACATITCACCCGATGGCAMT 
ATGTCTATATAGCOI~ CATAAQA1TCATGTGTATGAAAAQZA TGCTAATTQGACTITAACZCCATt GAAG 
ATGTCTATAT~cmoclcarallGATTCATGTQTATG IUIAOCATGCTaaTTGQACZTI'AACTCCATIQIUIQ 
mcelmacrrzaaracccrcomoaraaeara~vccnmmrMQMaccrlmoQTmoamccamecaa 
TCCCZZGACZITAATACC~TAACATATCTGTQOA~CAQGMACCTTmQOTTGGATGCCATCCCAA 
TGOCATGaaanamacTCAQM6ATCCTCCTQCATCMAQQmcmcQAATCCAOAACA TTCTAACAGAAG 
moca Toaaaa TmTCZZCZATQACTCMAOAATCTCMAQGmcrrmaaTCCMAACATTCTAACllGAAG 
aaCCZAAAOmaCACAGOTTTa~moeaeaomrmeuf~CAGTACMTlmeremmr~ 
AACCTAAMmA~TGCAGaaaamceacaomTTQZMQGCMTACAGTTGCCZCTGmTACIIAAGOGAAA 
C1QCTGATIOGCACAGTG1TTCACIUIAGCTCt TT~AGCTCTnacaoaccoat TTGCACCCATQCCATAAGCCGAA 
CTGCIGA TMOCACAGTQT1TCA~ACTGmaGCTCTAA 
ponl-20 
NH 000446 
FIG. 3. The sequence of PON1-20 was aligned with NM 000446, the known 
sequence of PON 1 Irom the NCBI database. There are five differences that are boxed. 
Two of them result in the RI92 and and L55 isoforms when translated, two do not alter 
the amino acid sequence, and the final difference could be an new isoform. 
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The sequence was then translated into the amino acid residues (Fig. 4). At position 55 
there was a leucine and at position 192 there was an arginine. PON la]9$ has greater 
paraoxon hydrolysis and less hydrolysis activity with diazon, soman, and sarin when 
compared to PON1Q]9$ the other common isoform. PON1Lss has not been shown to 
have an impact on enzyme activity, but results in a higher serum PON1 concentration 
when compared to PON1 xus (2). Mutagenesis will be used to create all four isoform 
combinations for enzyme activity and structure comparisons. The guanine substituted 
for adenine resulted in pT-Adv- ponl-20 and pT-Adv- ponl-22 having an arginine at 
position 146 rather than a glutamine. Mutagenesis will also be used to change 146 to 
glutamine for comparison. 
GAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCG 
GCTTCCGACCATGGCGAAGCTGATTGCGCTCACCCTCTTGGGGATGGGACTGGCACTCTTCAGGAACCACCAGTCTCCTTACCAAACACG 
M A K L I A L T L L G M G L A L F R N H Q S P Y Q T R 
ACTTAATGCTCTCCGAGAGGTACAACCCGTAGAACTTCCTAACTGTAATTTAGTTAAAGGAATCGAAhCTGGCTCTGAAGACTTGGAGA1 
L N A L R E V Q P V E L P N C N L V K G I E T G S E D L E I 
ACTGCCTAATGGACTGGCTTTCATTAGCTCTGGATTAAAGTATCCTGGAATAAAGAGCTTCAACCCCAACAGTCCTGGAAAAATACTTC'I 
L P N G L A F I S S G L K Y P G I K S F N P N S P G K I L 
GATGGACCTGAATGAAGAAGATCCAACAGTGTTGGAATTGGGGATCACTGGAAGTAAATTTGATGTATCTTCATTThACCCTCATGGGAT 
M D L N E E D F T V L E L G I T G S K F D V S S F N I' H G I 
TAGCACATTCACAGA'IGIAGITPATGCCATGTACCTCCTGGTGGTGAACCATCCAGATGCCAAGTCCACAGTGGAGTTGTTTAAATTTCG 
S T F T D E D N A M Y L L V V N H P D A K S T V E L I' K F R 
AGAAGPAGAAAAATCGCTTTTGClTCTAAAAACClTCAGACATAAACTTCTCCCTAATTTGAATGATATTGTTGCTGTGGGACCTGAGCA 
E E E K S L I H L K T I R H K L L P N L N D I V A V G P E H 
CTTTTATGGCACAAATGATCACTATTTTCTTGlCCCCTACTTACGATCCTGGGAGATGTATTTGGGTTTAGCGTGGTCGTATGTTGTCTA 
F Y G T N D H Y F L D P Y I R S W E M Y L G L A W S Y V V I 
CTATAGTCCAAGTGAAGTTCGAGTGG1'GGCAGAAGGATTTGATTTTGCTAATGGAATCAACATTTCACCCGATGGCAAGTATGTCTATA'I 
Y S P S E V R. V V A E G F D F A N G I N I S P D G K Y V Y I 
AGCTGAGTTGCTGGCTCATAAGATTCATGTGTATGPAAAGCATGCTAATTGGACTTTAACTCCATTGAAGTCCCTTGACTTTAATACCCT 
A E L L A H K I H V Y E K H A N W T L T P L K S L D F N T I 
CGTGGATAACATATCTGTGGATCCTGAGACAGGAGPCCTTTGGGTTGGATGCCATCCCAATGGCATGAAAATCTTCTTCTATGACTCAGA 
V ~ N I S V D P E T G D L W V G C H P N G M K I F F Y D S F 
GAATCCTCCTGCATCPGAGGI'GC1'TCGAATCCPGAACATTCTAACAGAAGAACCTAAAGTGACACAGGTTTATGCAGAAAATGGCACAG1 
N P P A S E V L R I Q N I L T E E P K V T Q V Y A E N G T 
GTTGCAGGGCAbTACAGTTGCCTCTGTGTACAAAGGGAAlCTGCTGATTGGCACAGTGTTTCACAAAGCTCTTTACTGTGAGCTCTAACA 
L Q G S T V A S V Y K G K L L I G T V F H K A L Y C E L 
GACCGATTTGCACCCATGCCATAAGCCGAATTCCAGCACACTGGCGGCCGTTACTAi 
FIG. 4. Amino acid sequence of PON 1 aligned with the DNA sequence. 
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PON I EXPRESSION 
Two PCR products, ponl-20' and ponl-20"'resulting Irom amplification with the 
ponl-nde and ponl-sap primers were ligated into pCRT7-TOPO and sequenced. The 
sequencing results verified that the restriction sites had been successfully introduced 
without mutation. Enzyme digests using Sapi and NdeI cut pTYBI and PCRT7-ponl- 
20 and pCRT7-ponl-20 as expected. (Fig. 5). 
FIG. 5. Gel showing successful digests with Sapi and Itidei. pTYBI is shown 
uncut (lane 2) and cut with both Sapl and Ndel (lane 3). Lanes 4 and 5 include uncut 
and cut pon1-20, and lanes 6 and 7 show ponl-20 uncut and cut. The double 
digests of ponl-20 and ponl-20 released the expected I kb Iragment. 
d hgsted with simitstly 
he rescdtittg co 4nies te 
uct pTYSt-pont-20 
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The inclusion body was isolated by cennifugation and solubilized using 8M urea 
as a denshumt. High concentration denaturants completely disrupt the protein structure, 
also known as unfolding (2). The buffer also included Tris-HCl, a bufler, EDTA, and 
dithithreitol (DTT). DTT is a reducing agent used to maintain cysteine residues and 
prevent non-native intra- and inter-disulfide bond formation (2). An attempted removal 
of the DTT led to the pmtein becoming insoluble again (gel not shown). PON 1 is 
known to have three- cysteine residues in positions 41, 283, and 352 capable of forming 
disulfide bonds (5). The next attempt at renanumion involved removal of excess d~ (urea) by dilution (Fig. 7). 
Std. 8M 6M 4M 2M 
Sol DC Sol DC Sol DC, 
F' 
FIG. 7. SDS-PAGE showing urea step gradient dilution. The soluble &actions 
(sol) with their corresponding dilution control (DC) are shown. Bands of matching 
intensity between sol and DC indicate that the protein remained soluble at all 4 
concentrations of urea. 
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The urea dilution results indicated that the urea concentration could be decreased while 
the protein remained soluble. Each concentration was used in a paraoxonase spot assay, 
but aller a 2-hour incubation no activity was observed. The lack of activity indicates 
thai the protein is not folded properly. The presence of DTT could cause a problem 
because Cys 41 and Cys 352 form a disulfide-bond essential for paraoxonase activity of 
the enzyme (5). Other methods of maintaining solubility should be attempted. A metal 
catalyst and reducing agent might be necessary to facilitate disulfide-bond reshuffling to 
permit proper folding and low molecular weight additives, such as arginine, might 
improve refolding. Insertion of a eukaryotic gene into a bacterial expression system 
often leads to inclusion body formation. A eukaryotic expression system, such as Pichia 
or Baculovirus, might produce soluble PON I enzyme. 
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CONCLUSION 
In this study pon J was initially located in a human liver cDNA library. The gene was 
cloned and sequenced, then compared to the known ponl sequence. Restriction enzyme 
sites were added to the ends ofpon1, then by a digest and a ligation pon1 was inserted 
into p TYBI, the expression vector. Protein overexpression was obtained in the BL21- 
star host strain, but it was insoluble. Inclusion body isolation and purification steps were 
performed. Refolding of the protein did not result in recovery of activity, as determined 
by a paraoxonase spot assay. Further studies will include use of different expression 
systems and other refolding techniques. Mutagenesis will be used to create the four 
known isoform combinations (RI92L55, R192M55, Q192L55, and Q192M55) and to 
change the arginine at 146 to the glutamine present in the known sequence. The mutants 
will be compared in activity assays and be crystalized to compare structural 
characteristics. 
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